Search for: "In re N.D. & M.D"
Results 161 - 180
of 196
Sorted by Relevance
|
Sort by Date
26 May 2011, 10:54 am
Supp.2d ___, 2011 WL 1898867 (N.D. [read post]
19 Jul 2022, 2:59 pm
BioMimetic Therapeutics, Inc., 2013 WL 139521, at *13-14 (M.D. [read post]
1 Oct 2015, 6:00 am
Michael (N.D. [read post]
2 Dec 2015, 12:38 pm
In re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Prod. [read post]
10 Jan 2023, 7:12 am
Del. 2021), Tractor Supply (M.D. [read post]
24 Jul 2017, 8:13 am
See, e.g., In re Sears, Roebuck & Co. [read post]
2 Oct 2008, 12:36 pm
Danek Medical, Inc., 1999 WL 1054864, *6 (M.D. [read post]
29 Jul 2019, 7:34 pm
Alonso, M.D., Def. [read post]
28 May 2020, 5:29 am
Despite the confusing verbiage, these judicial rulings are a serious deviation from the text of Rule 702, as well as the Advisory Committee Note to the 2000 Amendments, which embraced the standard articulated in In re Paoli, that “any step that renders the analysis unreliable . . . renders the expert’s testimony inadmissible. [read post]
7 Jun 2007, 10:52 am
Merck &;amp; Co., 961 F. [read post]
6 Aug 2021, 11:00 am
F&G International Group Holdings, LLC, No. 20-cv-73 (S.D. [read post]
24 Jan 2014, 12:57 am
In the course of doing some Internet research, I noted that D&O maven Dan Bailey of the Bailey & Cavalieri law firm had recently published an article on the topic. [read post]
21 Apr 2010, 12:08 pm
So those three are all we’re discussing today – three, no more, no less. [read post]
28 Oct 2011, 7:00 am
Supp. 1401, 1405 (N.D. [read post]
8 Oct 2015, 5:00 am
Oct. 15, 2009) (plaintiff’s burden of proving causation in a warning case “is well settled” law); In re Aredia & Zometa Products Liability Litigation, 2009 WL 2496873, at *2 (M.D. [read post]
10 Dec 2015, 2:00 am
F & M Equipment, Ltd., f/k/a Furnival Machinery Company, __ F.3d __ (3rd Cir. [read post]
27 Aug 2010, 2:41 pm
Searle & Co., 707 F. [read post]
1 Nov 2021, 8:09 am
Disruption Theory LLC, No. 20-cv-06919 (N.D. [read post]
27 Mar 2017, 1:43 pm
Rector & Visitors of Univ. of Va., 515 U.S. 819, 835-36 (1995). [read post]
23 Jan 2020, 10:37 pm
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
